| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 309 | 96 | 5 |
| Full Text Views | 3 | 1 | 0 |
| PDF Downloads | 2 | 2 | 0 |
Topical Diethylcarbamazine in the Treatment of Ocular Onchocerciasis
Moshe Lazar
Moshe Lazar
Department of Ophthalmology, Mount Sinai School of Medicine, the City University of New York, Fifth Avenue and 100th Street, New York, N. Y. 10029
Search for other papers by Moshe Lazar in
Current site
Google Scholar
PubMed
Search for other papers by Moshe Lazar in
Current site
Google Scholar
PubMed
Theodore W. Lieberman
Theodore W. Lieberman
Department of Ophthalmology, Mount Sinai School of Medicine, the City University of New York, Fifth Avenue and 100th Street, New York, N. Y. 10029
Search for other papers by Theodore W. Lieberman in
Current site
Google Scholar
PubMed
Search for other papers by Theodore W. Lieberman in
Current site
Google Scholar
PubMed
Irving H. Leopold
Irving H. Leopold
Department of Ophthalmology, Mount Sinai School of Medicine, the City University of New York, Fifth Avenue and 100th Street, New York, N. Y. 10029
Search for other papers by Irving H. Leopold in
Current site
Google Scholar
PubMed
Search for other papers by Irving H. Leopold in
Current site
Google Scholar
PubMed
An ophthalmic preparation of diethylcarbamazine may be a useful addition to presently available methods of treating onchocerciasis. Studies in animals showed good penetration of such a preparation into the anterior segment of the eye, that portion that is most commonly affected by the disease. No toxicity to the eye was found during an 8-week period of sustained local treatment of rabbits with the agent. We recommend appropriate field trials to assess the toxicity, the therapeutic efficacy, and the prophylactic uses of an ophthalmic preparation of diethylcarbamazine.
Author Notes
On leave from Tel-Hashomer Hospital, Israel.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 309 | 96 | 5 |
| Full Text Views | 3 | 1 | 0 |
| PDF Downloads | 2 | 2 | 0 |